Archive for February 2023

Komen’s free, virtual 10-week patient navigation training program provides specific training for patient navigators to ensure they can help Black patients overcome barriers to receiving high-quality care and treatment. The patient navigation training program takes a multifaceted approach to addressing inequities and barriers in the health care system, first and foremost by connecting patients to resources and support at every step of their breast care journey. We are excited to discuss how Komen trains patient navigators to be culturally responsive with Kelley Moultry, Komen’s Patient Navigation and Outreach Coordinator.

As we celebrate Black History Month, it is our honor to be joined today by a woman truly making history and one that I know we will be seeing much more from in the future. Dr. Zainab Shonibare, recently graduated from her PhD in 2022, is a reproductive cancer researcher at Yale University and the first Black postdoctoral researcher in her lab. Her story underscores why representation matters and diversity in research is so important, and Dr. Shonibare is here today to share her story and tell us about the focus of her research.

Tomorrow is Valentine’s Day! But we’re kicking things off a day early with a conversation about LOVE and breast cancer. February 14th it isn’t red roses and champagne toasts for everyone, and today’s conversation about LOVE reminds us of that. Se’Nita Harris was diagnosed with aggressive, triple negative breast cancer at age 37, before she found love. LaToya Bolds-Johnson was diagnosed with stage 3C triple negative breast cancer at age 36. She is married with three young girls and struggling to love the skin she’s in after treatment for her breast cancer. Whether you’re in love or looking to find love breast cancer changes you – physically, emotionally, mentally, sexually. Ladies, thank you for being on today’s show to talk about your own personally struggles to love and be loved.

Genetic testing gives people the chance to learn if they’re at a higher risk of breast cancer, if their family history of breast cancer, or if their breast cancer is due to an inherited gene mutation. In the past, breast cancer genetic testing only checked for inherited gene mutations in BRCA1 and BRCA2 genes. However, we’ve seen tremendous advancements and genetic discoveries in recent years, and it’s now common to be tested not only for BRCA 1 and 2 gene mutations, but also for mutations in multiple other high-risk genes. Today’s guest, Laurel Pointer, has felt the impact of these advancements first-hand in her family over the past two decades and is here to share her story with us. Laurel, welcome back to the show!